Juvenile Chronic Polyarthritis
Also known as: Juvenile arthritis, unspecified / Arthritis, Juvenile / Juvenile arthritis / Juvenile idiopathic arthritis / Juvenile idiopathic arthritis (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB06273 | Tocilizumab | An interleukin-6 (IL-6) receptor antagonist used to treat Cytokine Release Syndrome (CRS), Systemic Juvenile Idiopathic Arthritis (sJIA), Giant Cell Arteritis (GCA), and Rheumatoid Arthritis (RA). |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB06273 | Tocilizumab | Interleukin-6 receptor subunit alpha | target |
| DB06273 | Tocilizumab | Cytochrome P450 3A4 | enzyme |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00005 | Etanercept | 4 | Completed | 1 |
| DB00563 | Methotrexate | 4 | Completed | 1 |
| DB00860 | Prednisolone | 4 | Completed | 1 |
| DB00635 | Prednisone | 4 | Completed | 1 |